DexCom, Inc. (DXCM)
DexCom, Inc. (DXCM) Analyst/Investor Day Transcript
DexCom, Inc. (DXCM) Analyst/Investor Day Transcript
3 Reasons Analysts Love DexCom
While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes. With about 40 million people in the United States suffering from diabetes, and incidents of type 2 diabetes rising across multiple demographics, this core function of this class of medicines is still just as relevant as it was when these drugs first became available.
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
DXCM stock jumps on Q1 beat as revenues rise 15% and margins expand, with strong CGM demand and raised profitability outlook boosting momentum.
DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript
DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates
DexCom (DXCM) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.32 per share a year ago.
DXCM or MASI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either DexCom (DXCM) or Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?
Why DexCom (DXCM) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
DexCom's Q1 results may see strong growth from G7 uptake and CGM demand, but pricing mix and rising investments could weigh on margins.
Cwm LLC Sells 91,609 Shares of DexCom, Inc. $DXCM
Cwm LLC reduced its stake in shares of DexCom, Inc. (NASDAQ: DXCM) by 57.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 67,380 shares of the medical device company's stock after selling 91,609 shares during the quarter. Cwm LLC's holdings in DexCom
A Look at DexCom Inc (DXCM) After 3.1% Decline -- GF Value $109.23 vs Price $62.60
On April 21, 2026, DexCom Inc (DXCM) shares fell 3.1%, bringing the current price to $62.60. The stock has experienced a challenging year, with a 52-week range
Here's Why You Should Add DexCom Stock to Your Portfolio Now
DexCom's expanding CGM market, G7 rollout, and global growth momentum position it for gains, despite pricing pressure and near-term margin risks.
DexCom (DXCM) Upgraded to Buy: Here's Why
DexCom (DXCM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
